Seeing Is Believing
HUMA is currently covered by 5 analysts with an average price target of $8.53. This is a potential upside of $4.71 (123.3%) from yesterday's end of day stock price of $3.82.
Humacyte's activity chart (see below) currently has 10 price targets and 22 ratings on display. The stock rating distribution of HUMA is 6.67% SELL, 86.67% BUY and 6.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 5.56% with an average time for these price targets to be met of 5.67 days.
Highest price target for HUMA is $15, Lowest price target is $3, average price target is $8.53.
Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 01-Apr-2024. First documented stock forecast 20-Jul-2021.
Currently out of the existing stock ratings of HUMA, 1 are a SELL (6.67%), 13 are a BUY (86.67%), 1 are a HOLD (6.67%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7
$3.18 (83.25%)
7
24 days ago
0/5 (0%)
$3.99 (132.56%)
Buy
15
$11.18 (292.67%)
1 months ago
0/5 (0%)
$11.86 (377.71%)
Hold
3
$-0.82 (-21.47%)
5 months 15 days ago
1/3 (33.33%)
$0.65 (27.66%)
34
Buy
8
$4.18 (109.42%)
10
1 years 29 days ago
0/4 (0%)
$4.76 (146.91%)
Buy
5
$1.18 (30.89%)
12
1 years 4 months 6 days ago
0/3 (0%)
$2.79 (126.24%)
What is HUMA (Humacyte) average time for price targets to be met?
Which analyst has the current highest performing score on HUMA (Humacyte) with a proven track record?
Which analyst has the current lower performing score on HUMA (Humacyte) with a proven track record?
Which analyst has the most public recommendations on HUMA (Humacyte)?
Which analyst is the currently most bullish on HUMA (Humacyte)?
Which analyst is the currently most reserved on HUMA (Humacyte)?